Skip to content

Prospective cohort study of compound sanqi ointment in preventing radiation dermatitis of breast cancer

Prospective cohort study of compound sanqi ointment in preventing radiation dermatitis of breast cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113836
Enrollment
Unknown
Registered
2025-12-03
Start date
2025-08-12
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Sanqi ointment group :None
Routine care group:None

Sponsors

Zhejiang University school of the Medicine First Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with breast cancer and receiving postoperative radiotherapy. 2. Age >= 18 years old. 3. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. There are underlying skin diseases such as psoriasis, eczema, lupus erythematosus, etc. 2. There are skin injuries, dermatitis, and poor wound healing in the radiation area before radiotherapy. 3. Allergic to the ingredients of the ointment. 4. Unable to cooperate with the research.

Design outcomes

Primary

MeasureTime frame
The incidence of >= grade 2 radiation dermatitis;

Secondary

MeasureTime frame
Time of occurrence of radiation dermatitis;Recovery time of radiation dermatitis;

Countries

China

Contacts

Public ContactZhijun Dai

Zhejiang University school of the Medicine First Affiliated Hospital

dzj0911@126.com+86 157 0581 9132

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026